These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19158444)

  • 1. Cytogenetic analysis of false-positive mucosa by photodynamic diagnosis using 5-aminolevulinic acid - possible existence of premalignant genomic alterations examined by in vitro experiment.
    Matsuyama H; Yamamoto Y; Nagao K; Ohmi C; Sakano S; Sasaki K
    Oncology; 2009; 76(2):118-25. PubMed ID: 19158444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
    Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
    Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
    Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
    Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
    Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
    Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
    Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
    BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of false positives in 5-aminolevulinic acid-induced photodynamic diagnosis of bladder carcinoma: identification of patient groups that may benefit most from highly specific optical diagnostics.
    Draga RO; Grimbergen MC; Kok ET; Jonges TN; Bosch JL
    Urology; 2009 Oct; 74(4):851-6. PubMed ID: 19683800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic imbalances in urothelial cancer: intratumor heterogeneity versus multifocality.
    Prat E; Del Rey J; Camps J; Ponsa I; Lloreta J; Egozcue J; Gelabert A; Campillo M; Miro R
    Diagn Mol Pathol; 2008 Sep; 17(3):134-40. PubMed ID: 18382360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic characterization and diagnostics of bladder cancer.
    Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
    Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer.
    Kipp BR; Tyner HL; Campion MB; Voss JS; Karnes RJ; Sebo TJ; Halling KC; Zhang J
    Am J Clin Pathol; 2008 Oct; 130(4):552-9. PubMed ID: 18794047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic instability in superficial bladder cancer and adjacent mucosa: an interphase cytogenetic study.
    Cianciulli AM; Leonardo C; Guadagni F; Marzano R; Iori F; De Nunzio C; Franco G; Merola R; Laurenti C
    Hum Pathol; 2003 Mar; 34(3):214-21. PubMed ID: 12673554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic evaluation of fluorescence diagnosis in bladder cancer.
    Junker K; Kania K; Fiedler W; Hartmann A; Schubert J; Werner W
    Int J Oncol; 2002 Mar; 20(3):647-53. PubMed ID: 11836583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluorescence diagnosis and photodynamic therapy in urology].
    Stepp H; Waidelich R
    Aktuelle Urol; 2007 Nov; 38(6):455-64. PubMed ID: 17987533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is aneusomy of chromosome 9 alone a valid biomarker for urinary bladder cancer screening?
    Panani AD; Kozirakis D; Anastasiou J; Babanaraki A; Malovrouvas D; Roussos C
    Anticancer Res; 2006; 26(2A):1161-5. PubMed ID: 16619518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy for superficial bladder cancer.
    Shackley DC; Briggs C; Whitehurst C; Betts CD; O'Flynn KJ; Clarke NW; Moore JV
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):523-30. PubMed ID: 12113084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
    Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
    J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
    Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R
    J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions.
    Zaak D; Hungerhuber E; Schneede P; Stepp H; Frimberger D; Corvin S; Schmeller N; Kriegmair M; Hofstetter A; Knuechel R
    Cancer; 2002 Sep; 95(6):1234-8. PubMed ID: 12216090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
    Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
    J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.